BWXT Medical's Annual Compliance Report Available

Each year, BWXT Medical is required to submit an Annual Compliance Report (ACR) to Canada’s nuclear regulator, the Canadian Nuclear Safety Commission (CNSC).

The purpose of the ACR is to demonstrate adherence to BWXT Medical’s commitment to operate a safe Class IB nuclear substance processing facility, as well as demonstrate compliance with the applicable regulations and licence conditions specified by the CNSC. The ACR, which is reviewed by CNSC Staff, provides information related to BWXT Medical’s performance across the CNSC’s 14 Safety and Control Areas.

The ACR is made available to the public and is posted on our website. Contact us by email at isotopequestions@bwxt.com or by phone at 1.833.657.4565 if you have any questions.

Canadian Nuclear Safety Commission's Independent Environmental Monitoring Program Results

The Canadian Nuclear Safety Commission (CNSC) has made available the results of its 2023 Independent Environmental Monitoring Program (IEMP) sampling results from areas around BWXT Medical's Kanata facility at 447 March Road.

As noted by the CNSC, “IEMP results from 2016, 2018 and 2023 are consistent with the results submitted by Nordion and BWXT Medical, supporting our assessment that the licensees’ environmental protection programs are effective. The results add to the body of evidence that people and the environment in the vicinity of the Nordion and BWXT Medical facilities are protected and that there are no anticipated health impacts from the operation of the facilities on the site.”

Contact Us: